Global Transcutaneous Neurostimulators Market Insights, Research, Forecast to 2025

Published On: Jul 2019

Format: PDF

Publisher: Qy Research

Pages: 114

Report ID: 12719

The global Transcutaneous Neurostimulators market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Transcutaneous Neurostimulators market based on company, product type, end user and key regions.

This report studies the global market size of Transcutaneous Neurostimulators in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Transcutaneous Neurostimulators in these regions.
This research report categorizes the global Transcutaneous Neurostimulators market by top players/brands, region, type and end user. This report also studies the global Transcutaneous Neurostimulators market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
ElectroCore Medical
NEUROMetrix
Neurosigma
Quell
Vygon 

Market size by Product
Sensory Nerve Stimulation
Vagus Nerve Stimulation
Peripheral Nerve Stimulation
Market size by End User
Hospiatl
Clinic

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Transcutaneous Neurostimulators market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Transcutaneous Neurostimulators market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Transcutaneous Neurostimulators companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Transcutaneous Neurostimulators submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Transcutaneous Neurostimulators are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Transcutaneous Neurostimulators market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Transcutaneous Neurostimulators Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Transcutaneous Neurostimulators Market Size Growth Rate by Product
1.4.2 Sensory Nerve Stimulation
1.4.3 Vagus Nerve Stimulation
1.4.4 Peripheral Nerve Stimulation
1.5 Market by End User
1.5.1 Global Transcutaneous Neurostimulators Market Size Growth Rate by End User
1.5.2 Hospiatl
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Transcutaneous Neurostimulators Market Size
2.1.1 Global Transcutaneous Neurostimulators Revenue 2014-2025
2.1.2 Global Transcutaneous Neurostimulators Sales 2014-2025
2.2 Transcutaneous Neurostimulators Growth Rate by Regions
2.2.1 Global Transcutaneous Neurostimulators Sales by Regions
2.2.2 Global Transcutaneous Neurostimulators Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Transcutaneous Neurostimulators Sales by Manufacturers
3.1.1 Transcutaneous Neurostimulators Sales by Manufacturers
3.1.2 Transcutaneous Neurostimulators Sales Market Share by Manufacturers
3.1.3 Global Transcutaneous Neurostimulators Market Concentration Ratio (CR5 and HHI)
3.2 Transcutaneous Neurostimulators Revenue by Manufacturers
3.2.1 Transcutaneous Neurostimulators Revenue by Manufacturers (2014-2019)
3.2.2 Transcutaneous Neurostimulators Revenue Share by Manufacturers (2014-2019)
3.3 Transcutaneous Neurostimulators Price by Manufacturers
3.4 Transcutaneous Neurostimulators Manufacturing Base Distribution, Product Types
3.4.1 Transcutaneous Neurostimulators Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Transcutaneous Neurostimulators Product Type
3.4.3 Date of International Manufacturers Enter into Transcutaneous Neurostimulators Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Transcutaneous Neurostimulators Sales by Product
4.2 Global Transcutaneous Neurostimulators Revenue by Product
4.3 Transcutaneous Neurostimulators Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Transcutaneous Neurostimulators Breakdown Data by End User

6 North America
6.1 North America Transcutaneous Neurostimulators by Countries
6.1.1 North America Transcutaneous Neurostimulators Sales by Countries
6.1.2 North America Transcutaneous Neurostimulators Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Transcutaneous Neurostimulators by Product
6.3 North America Transcutaneous Neurostimulators by End User

7 Europe
7.1 Europe Transcutaneous Neurostimulators by Countries
7.1.1 Europe Transcutaneous Neurostimulators Sales by Countries
7.1.2 Europe Transcutaneous Neurostimulators Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Transcutaneous Neurostimulators by Product
7.3 Europe Transcutaneous Neurostimulators by End User

8 Asia Pacific
8.1 Asia Pacific Transcutaneous Neurostimulators by Countries
8.1.1 Asia Pacific Transcutaneous Neurostimulators Sales by Countries
8.1.2 Asia Pacific Transcutaneous Neurostimulators Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Transcutaneous Neurostimulators by Product
8.3 Asia Pacific Transcutaneous Neurostimulators by End User

9 Central & South America
9.1 Central & South America Transcutaneous Neurostimulators by Countries
9.1.1 Central & South America Transcutaneous Neurostimulators Sales by Countries
9.1.2 Central & South America Transcutaneous Neurostimulators Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Transcutaneous Neurostimulators by Product
9.3 Central & South America Transcutaneous Neurostimulators by End User

10 Middle East and Africa
10.1 Middle East and Africa Transcutaneous Neurostimulators by Countries
10.1.1 Middle East and Africa Transcutaneous Neurostimulators Sales by Countries
10.1.2 Middle East and Africa Transcutaneous Neurostimulators Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Transcutaneous Neurostimulators by Product
10.3 Middle East and Africa Transcutaneous Neurostimulators by End User

11 Company Profiles
11.1 ElectroCore Medical
11.1.1 ElectroCore Medical Company Details
11.1.2 Company Business Overview
11.1.3 ElectroCore Medical Transcutaneous Neurostimulators Sales, Revenue and Gross Margin (2014-2019)
11.1.4 ElectroCore Medical Transcutaneous Neurostimulators Products Offered
11.1.5 ElectroCore Medical Recent Development
11.2 NEUROMetrix
11.2.1 NEUROMetrix Company Details
11.2.2 Company Business Overview
11.2.3 NEUROMetrix Transcutaneous Neurostimulators Sales, Revenue and Gross Margin (2014-2019)
11.2.4 NEUROMetrix Transcutaneous Neurostimulators Products Offered
11.2.5 NEUROMetrix Recent Development
11.3 Neurosigma
11.3.1 Neurosigma Company Details
11.3.2 Company Business Overview
11.3.3 Neurosigma Transcutaneous Neurostimulators Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Neurosigma Transcutaneous Neurostimulators Products Offered
11.3.5 Neurosigma Recent Development
11.4 Quell
11.4.1 Quell Company Details
11.4.2 Company Business Overview
11.4.3 Quell Transcutaneous Neurostimulators Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Quell Transcutaneous Neurostimulators Products Offered
11.4.5 Quell Recent Development
11.5 Vygon 
11.5.1 Vygon  Company Details
11.5.2 Company Business Overview
11.5.3 Vygon  Transcutaneous Neurostimulators Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Vygon  Transcutaneous Neurostimulators Products Offered
11.5.5 Vygon  Recent Development

12 Future Forecast
12.1 Transcutaneous Neurostimulators Market Forecast by Regions
12.1.1 Global Transcutaneous Neurostimulators Sales Forecast by Regions 2019-2025
12.1.2 Global Transcutaneous Neurostimulators Revenue Forecast by Regions 2019-2025
12.2 Transcutaneous Neurostimulators Market Forecast by Product
12.2.1 Global Transcutaneous Neurostimulators Sales Forecast by Product 2019-2025
12.2.2 Global Transcutaneous Neurostimulators Revenue Forecast by Product 2019-2025
12.3 Transcutaneous Neurostimulators Market Forecast by End User
12.4 North America Transcutaneous Neurostimulators Forecast
12.5 Europe Transcutaneous Neurostimulators Forecast
12.6 Asia Pacific Transcutaneous Neurostimulators Forecast
12.7 Central & South America Transcutaneous Neurostimulators Forecast
12.8 Middle East and Africa Transcutaneous Neurostimulators Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Transcutaneous Neurostimulators Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer